Brenner Erin K.

Chief Product Dev. Officer at Pear Therapeutics, Inc.

Sold, on record
$10k
Dollars the filings state
Form 4 sales
1
Latest Jan 20, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
1
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale Pear Therapeutics, Inc.Plan not stated
    Jan 20, 2023 2023

    Sold 8,690 shares at $1.13 ($10k)

    Brenner Erin K., Chief Product Dev. Officer

    Sold 16.7% of holdings ($59k position)43,310 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Brenner Erin K.
Source
Jan 20, 2023Jan 24, 2023Pear Therapeutics, Inc.Chief Product Dev. OfficerForm 4 sale8,690$10k16.7%Plan not statedSEC